“…Several cyclic and bicyclic dipeptide analogues intended to stabilize the peptide in a reverse turn have been reported. − Among these, the 5,5-bicyclic dipeptidomimetic 1 was designed as a type II β-turn mimetic and the 6,5-bicyclic dipeptidomimetic BTD 2 as a type II‘ β-turn mimetic (Chart ). BTD has been extensively studied and used for diverse biological applications. ,− BTD and the related 4,5-bicyclic, 5,5-bicyclic, 7,5-bicyclic, and 7,6-bicyclic core structures are most frequently synthesized by reaction sequences where ring closure by intramolecular N-acylation constitutes the last step. − While numerous investigations have been devoted to constrained bicyclic dipeptides, studies of the corresponding bicyclic tripeptides are rare. Access to reliable methods that, on solid phase, allow for construction of well-defined constrained tripeptide units and that constitute a complement to the commonly used disulfide-based cyclization procedures is highly desirable.…”